SUBCHAPTER X— MISCELLANEOUS

Release point 118-16 · current through 10/02/2023

Sections

• § 391 Separability clause
• § 392 Exemption of meats and meat food products
• § 393 Food and Drug Administration
• § 393a Office of Pediatric Therapeutics
• § 394 Scientific review groups
• § 395 Loan repayment program
• § 396 Practice of medicine
• § 397 Contracts for expert review
• § 398 Notices to States regarding imported food
• § 399 Grants to enhance food safety
• § 399a Office of the Chief Scientist
• § 399b Office of Women’s Health
• § 399c Improving the training of State, local, territorial, and tribal food safety officials
• § 399d Employee protections
• § 399e Nanotechnology
• § 399f Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups
• § 399g Food and Drug Administration Intercenter Institutes
• § 399h National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing
• § 399i Food and Drug Administration Working Capital Fund